IP Library Granted Patent US 8,372,136
Granted Patent B2
US 8,372,136 · App. 12/758,687 · Granted Feb 12, 2013

Implants having high fatigue resistance, implant delivery systems, and methods of use

Inventors: Hussain S. Rangwala (Edina, MN); Zhiyong Zhang (Edina, MN); Robert Wayne VanPelt, Jr. (Saint Paul, MN); William Joseph Whealon (Chaska, MN)
Assignee: Covidien LP
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,136
App. No.
12/758,687
Granted
Feb 12, 2013
Kind
B2
Abstract

According to one aspect of the present invention, a fatigue resistant stent includes a flexible tubular structure having an inside diameter, an outside diameter, and a sidewall therebetween and having apertures extending through the sidewall. According to other aspects of the invention, processes for making a fatigue resistant stent are disclosed. According to further aspects of the invention, delivery systems for a fatigue resistant stent and methods of use are provided.

Claims (20)

1. A stent for implant in a mammalian body comprising:

a tubular structure having an inside diameter, an outside diameter, a sidewall therebetween, a central axis defining a longitudinal direction, and apertures extending through the sidewall, wherein said sidewall is a circumferential sidewall having a wall thickness, said apertures separating struts joined at apices, said apices having a structure to exhibit a level of tensile strain, said struts being generally longitudinally extending and having different widths with a plurality of the struts grouped to define a cell, wherein in the circumferential direction of the stent, each cell comprises a first group of struts having a first width and a second group of struts having a second width different from the first width, with apices that are adjacent in the circumferential direction being offset with respect to one another in the longitudinal direction, said stent having a length along the central axis, wherein elongation of the stent in the longitudinal direction causes a change in the level of tensile strain in the apices, wherein said stent is structured such that when elongated at least 10%, the level of tensile strain in each apex is less than about 3%.

2. The stent of claim 1 , wherein when the stent is elongated at least 10%, the level of tensile strain in each apex is less than about 2%.

3. The stent of claim 1 , wherein when the stent is elongated at least 20%, the level of tensile strain in each apex is less than about 3%.

4. The stent of claim 1 , wherein when the stent is elongated at least 30%, the level of tensile strain in each apex is less than about 3%.

5. The stent of claim 1 , wherein when the stent is elongated at least 40%, the level of tensile strain in each apex is less than about 3%.

6. The stent of claim 1 , wherein when the stent is elongated at least 50%, the level of tensile strain in each apex is less than about 3%.

7. The stent of claim 1 , wherein a tolerance level of tensile strain in each apex is about ±0.5%.

8. The stent of claim 1 , wherein at least some of said apices are opposed to one another when the stent is in an unexpanded configuration and are circumferentially offset from one another when the stent is in an expanded configuration.

9. The stent of claim 1 , wherein said tubular structure comprises a laser cut tube.

10. The stent of claim 1 , wherein said tubular structure comprises a wire joined at regions to form said struts and said apices.

11. The stent of claim 1 , wherein said tubular structure comprises a braid.

12. The stent of claim 1 , wherein the first group comprises three struts and the second group comprises five struts.

13. The stent of claim 12 , wherein adjacent cells are joined together in the circumferential direction by connecting a first strut of the first group to a last strut of the second group, as viewed in the circumferential direction.

14. The stent of claim 12 , wherein the struts in the first group have a smaller width and a smaller length than the struts in the second group.

15. The stent of claim 12 , wherein the struts in the first group have a greater width and a greater length than the struts in the second group.

16. The stent of claim 1 , wherein the apices of the first group have a different width than the apices of the second group.

17. The stent of claim 1 , wherein the second width is different from the first width by about 20%.

18. The stent of claim 1 , wherein the second width is different from the first width by about 10%.

19. The stent of claim 1 , wherein the first group of struts has a length that is different from a length of the second group of struts.

Assignments (3)
CHANGE OF NAME Recorded Nov 9, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029276/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2011
From: EV3, INC.
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 026955/0911 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: RANGWALA, HUSSAIN S.; ZHANG, ZHIYONG; VANPELT, JR., ROBERT WAYNE; WHEALON, WILLIAM JOSEPH
To: EV3 INC.
Reel/Frame 024506/0701 →
Continuity (2)
Provisional Application 61168215 · Apr 10, 2009
Related Publication 20100262227A1 · Oct 14, 2010